Outcome
    Moderate Evidence

    Saw Palmetto for Prostate Size Reduction

    Saw palmetto does not shrink the prostate in controlled trials.

    Overview

    Saw palmetto does not shrink the prostate in controlled trials.

    Verdict

    Not supported

    How It Works

    Any anti-androgenic or anti-inflammatory action is too weak to alter prostate volume.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Studied at 320-960 mg/day; no reduction in prostate volume was demonstrated in the large trials
    Expected timeframe
    Not established

    Protocol

    form
    Liposterolic Serenoa repens extract standardised to 85-95% fatty acids and sterols
    duration
    STEP ran 12 months and CAMUS 18 months, both adequate to detect volume change
    co factor
    Evidence indicates no effect. Prostate volume reduction is the specific pharmacological action of 5-alpha-reductase inhibitors, which shrink the gland by around 20-25% over 6-12 months. Saw palmetto does not reproduce this: the STEP and CAMUS trials found no significant reduction in prostate volume or in serum and intraprostatic DHT, and no improvement in urinary symptoms, at doses up to three times the standard. The 2012 Cochrane review of 32 trials in nearly 6,000 men found no benefit over placebo. The in vitro 5-alpha-reductase inhibition does not occur at concentrations achievable in human prostate tissue.
    titration
    Not applicable - dose escalation to 960 mg/day in the CAMUS trial produced no benefit
    starting dose
    Not recommended for this outcome. Trials used 320-960 mg/day of liposterolic extract

    Evidence

    What the studies say

    The CAMUS trial found no change in prostate volume or PSA at escalating doses. Cochrane reviews confirm no significant effect on prostate size compared with placebo.

    Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

    Score: 6/10
    2016
    systematic_review
    0

    Novara G, Giannarini G, Alcaraz A +4 more

    Hexanic extract reduced IPSS and nocturia versus placebo with a low rate of sexual adverse events.

    View source

    Safety

    Caveats

    If prostate volume reduction is the goal, finasteride and dutasteride achieve it reliably over 6-12 months and reduce the risk of acute urinary retention and the need for surgery - they also halve PSA readings, which the prescriber must account for, and carry sexual and mood side effects that need discussion. Alpha-blockers relieve symptoms faster without changing volume. Urinary symptoms need proper assessment rather than self-treatment, and acute urinary retention is a medical emergency; blood in the urine, weight loss or bone pain need prompt evaluation. Safety of saw palmetto: generally well tolerated, with mild gastrointestinal upset, nausea and headache. It may lower PSA readings, potentially masking prostate cancer detection - always tell your doctor if you are taking it before a PSA test. Weak antiplatelet activity with case reports of bleeding means caution with warfarin, direct oral anticoagulants, aspirin and antiplatelet drugs, and stopping two weeks before surgery. Rare liver injury and pancreatitis have been reported. It is contraindicated in pregnancy and in women who may become pregnant, since antiandrogens can cause genital malformation in a male fetus.

    Less likely to help if

    Everyone - the large trials found no volume reduction at any dose tested.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.